Practical considerations for therapies targeting the prostacyclin pathway
Therapies that target the prostacyclin pathway play a key role in the treatment of both early- and late-stage pulmonary arterial hypertension, and provide significant clinical benefits for patients. A number of agents have been approved, which are administered via intravenous, subcutaneous, inhaled...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2016-12-01
|
| Series: | European Respiratory Review |
| Online Access: | http://err.ersjournals.com/content/25/142/418.full |